Status:
COMPLETED
Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes
Lead Sponsor:
Sansum Diabetes Research Institute
Collaborating Sponsors:
Roche Pharma AG
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare those using a diabetes management smartphone application (mySugr) to those not using the application. This smartphone application is for Spanish-literate ...
Detailed Description
The aim of this pilot observation trial is to determine feasibility, acceptability, and impact of the combination of mySugr and structured self-monitored blood glucose (SMBG) for Spanish-literate Hisp...
Eligibility Criteria
Inclusion
- Adults ≥ 18 years of age at enrollment
- Self-reported Hispanic/Latino ethnicity
- Spanish-literate with Spanish as preferred language
- Diagnosis of T2D for at least 6 months
- HbA1c 7.5% - 10%
- mySugr-compatible smartphone
- Any glucose lowering therapy except rapid-acting mealtime insulin
- Residence in Central Coast of California -
Exclusion
- 1\. Type 1 diabetes 2. Use of rapid-acting mealtime insulin 3. Pregnancy 4. Any active clinically significant disease or disorder which in the investigator's opinion could interfere with participation in the study.
- \-
Key Trial Info
Start Date :
April 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05975242
Start Date
April 4 2023
End Date
April 1 2024
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sansum Diabetes Research Institute
Santa Barbara, California, United States, 93105